The Egyptian Drug Authority announced granting an emergency use license for the “Molnupiravir” drug, after passing the necessary assessments to deepen the localization of the pharmaceutical industry in Egypt. According to the authority’s statement, thanks to the continuous cooperation between the Egyptian Drug Authority and various state institutions and industry partners, Egypt will be the first country in the Middle East to issue an emergency registration license for a coronavirus drug – a global leap in the pharmaceutical industry locally. “Molnupiravir” is the first oral coronavirus treatment for adults at high risk, the authority explained, cutting the threat of hospitalization and death by half for mild to moderate cases. The drug will be restricted to hospitals only to ensure that it is used under full medical supervision. Egypt was the first country in the Middle East to locally manufacture remdesivir and favipiravir coronavirus drugs as well, and to achieve self-sufficiency in them and export the drug to various other countries.
